Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Styczynski

Showing results (111-120 of 155) with videos related to

Pageof 16
Sort By:
The Journal of Infection|November 10, 2021
Efficacy, safety and feasibility of treatment of chronic HCV infection with directly acting agents in hematopoietic stem cell transplant recipients - Study of infectious diseases working party of EBMTMalgorzata Mikulska, Nina Knelange, Laura Ambra Nicolini, et al.
Annals of Hematology|April 18, 2019
The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMTMartin Schmidt-Hieber, Gloria Tridello, Per Ljungman, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 2, 2026
Real-World Utilization Pattern and Outcomes of Letermovir in Adult Cytomegalovirus-Seropositive Allogeneic Hematopoietic Cell Transplant Recipients: An International Retrospective Study From the Infectious Diseases Working Party of EBMTJan Styczynski, Gloria Tridello, Nina Knelange, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2016
Impact of Donor Epstein-Barr Virus Serostatus on the Incidence of Graft-Versus-Host Disease in Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation: A Study From the Acute Leukemia and Infectious Diseases Working Parties of the European Society for Blood and Marrow TransplantationJan Styczynski, Gloria Tridello, Lidia Gil, et al.
Anticancer Research|July 18, 2008
Prognostic impact of combined fludarabine, treosulfan and mitoxantrone resistance profile in childhood acute myeloid leukemiaJan Styczynski, Mariusz Wysocki, Agnieszka Dluzniewska, et al.
Bone Marrow Transplantation|February 28, 2023
Risk factors for a severe disease course in children with SARS-COV-2 infection following hematopoietic cell transplantation in the pre-Omicron period: a prospective multinational Infectious Disease Working Party from the European Society for Blood and Marrow Transplantation group (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH) studyDina Averbuch, Rafael de la Camara, Gloria Tridello, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 18, 2013
Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow TransplantationJan Styczynski, Lidia Gil, Gloria Tridello, et al.
Haematologica|November 23, 2019
Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)Ibrahim Yakoub-Agha, Christian Chabannon, Peter Bader, et al.
Bone Marrow Transplantation|January 14, 2018
Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMTSimone Cesaro, Roberto Crocchiolo, Gloria Tridello, et al.
Leukemia & Lymphoma|October 24, 2012
Individualized tumor response testing profile has a prognostic value in childhood acute leukemias: multicenter non-interventional long-term follow-up studyMagdalena Piatkowska, Jan Styczynski, Beata Kolodziej, et al.
Pageof 16

Showing results (111-120 of 155) with videos related to

Sort By:
Pageof 16
The Journal of Infection|November 10, 2021
Efficacy, safety and feasibility of treatment of chronic HCV infection with directly acting agents in hematopoietic stem cell transplant recipients - Study of infectious diseases working party of EBMTMalgorzata Mikulska, Nina Knelange, Laura Ambra Nicolini, et al.
Annals of Hematology|April 18, 2019
The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMTMartin Schmidt-Hieber, Gloria Tridello, Per Ljungman, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 2, 2026
Real-World Utilization Pattern and Outcomes of Letermovir in Adult Cytomegalovirus-Seropositive Allogeneic Hematopoietic Cell Transplant Recipients: An International Retrospective Study From the Infectious Diseases Working Party of EBMTJan Styczynski, Gloria Tridello, Nina Knelange, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2016
Impact of Donor Epstein-Barr Virus Serostatus on the Incidence of Graft-Versus-Host Disease in Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation: A Study From the Acute Leukemia and Infectious Diseases Working Parties of the European Society for Blood and Marrow TransplantationJan Styczynski, Gloria Tridello, Lidia Gil, et al.
Anticancer Research|July 18, 2008
Prognostic impact of combined fludarabine, treosulfan and mitoxantrone resistance profile in childhood acute myeloid leukemiaJan Styczynski, Mariusz Wysocki, Agnieszka Dluzniewska, et al.
Bone Marrow Transplantation|February 28, 2023
Risk factors for a severe disease course in children with SARS-COV-2 infection following hematopoietic cell transplantation in the pre-Omicron period: a prospective multinational Infectious Disease Working Party from the European Society for Blood and Marrow Transplantation group (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH) studyDina Averbuch, Rafael de la Camara, Gloria Tridello, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 18, 2013
Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow TransplantationJan Styczynski, Lidia Gil, Gloria Tridello, et al.
Haematologica|November 23, 2019
Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)Ibrahim Yakoub-Agha, Christian Chabannon, Peter Bader, et al.
Bone Marrow Transplantation|January 14, 2018
Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMTSimone Cesaro, Roberto Crocchiolo, Gloria Tridello, et al.
Leukemia & Lymphoma|October 24, 2012
Individualized tumor response testing profile has a prognostic value in childhood acute leukemias: multicenter non-interventional long-term follow-up studyMagdalena Piatkowska, Jan Styczynski, Beata Kolodziej, et al.
Pageof 16